OR WAIT null SECS
Contract service providers must step up their game to stay competitive in increasingly complex bio/pharma market.
The need for preclinical testing expertise is growing as molecular complexity increases.
A look at the newest innovations offers a deeper understanding of affinity ligands and their role in the future of downstream processing.
March 25, 2010
Merck Ends Partnership With Dynavax; PhRMA Elects Officers; And More.
March 18, 2010
Abbott Agrees to Acquire Facet Biotech; FDA Issues Black-Box Warning For Plavix; and More.
March 11, 2010
Exelixis And XenoPort Announce Job Cuts; GSK Dedicates India Facility; And More.
March 04, 2010
Astellas Pharma Makes Bid for OSI Pharmaceuticals; Ringo Retiring From Pfizer; And More.
March 02, 2010
CMOs' business model has all of the flaws of the captive model it is meant to replace.
Could President Obama's tax reform, which is targeted at reducing outsourcing, endanger India's contract-services industry?
Emerging markets remain an important element in the strategies of pharmaceutical companies and their suppliers.
Pre-Interphex 2010 Product Releases.
To best carry out the vision of Hatch-Waxman, Congress must act now on biogenerics.
Contract manufacturers report improving business conditions, but will they continue?